Galen Brings OC Manufacturing In-House
This article was originally published in The Pink Sheet Daily
Galen will transfer manufacturing of its oral contraceptive Ovcon from Bristol Myers-Squibb to its newly-acquired plant in Fajardo, Puerto Rico
You may also be interested in...
This is the second launch delay for the chewable oral contraceptive. Warner Chilcott expects to transfer manufacturing of Ovcon from Bristol to a recently-acquired Pfizer plant.
The cardiologist panel calls for use of the congestive heart failure therapy to be "strictly limited" to patients that present with symptoms in the hospital setting. The expert panel also recommends that Scios "immediately undertake" a professional educational campaign about Natrecor's appropriate uses.